Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader dedicated to serving science, with a mission to enable its customers to make the world healthier, cleaner, and safer. The company provides a comprehensive range of analytical instruments, life sciences solutions, specialty diagnostics, and laboratory, pharmaceutical, and biotechnology services. Headquartered in Waltham, Massachusetts, U.S., Thermo Fisher Scientific supports a diverse customer base across various scientific and healthcare sectors.

The company's extensive portfolio includes analytical instruments, laboratory equipment, reagents, consumables, software, and services. These offerings are utilized by pharmaceutical and biotechnology companies, research institutions, hospitals, clinical diagnostic labs, universities, and government agencies. Key brands under Thermo Fisher Scientific include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD, providing integrated solutions for research, discovery, analysis, and manufacturing.

Recent notable developments include the company receiving the first FBI approval for Rapid DNA Crime Scene Profiles eligible for National CODIS Searches on July 7, 2026, and the launch of LabLink 360 Quality Assurance software to streamline quality control workflows in clinical laboratories. In June 2026, Thermo Fisher Scientific showcased new capabilities in manufacturing, clinical development, and AI-enabled research at BIO International, highlighting investments in biologics, sterile fill-finish, and AI-driven analytics. Leadership changes in January 2026 saw Gianluca Pettiti promoted to President and Chief Operating Officer, while financial analysts from Stifel, Goldman Sachs, and KeyBanc raised price targets, citing anticipated organic growth and improving conditions in the biopharma sector.